FIELD: medicine.
SUBSTANCE: invention is intended to predict the risk of developing diabetic foot syndrome in residents of Central Russia with type 2 diabetes. DNA is isolated and the polymorphic variant of the gene for activating transcription factor 6 ATF6 rs7517862 (G>C) is analyzed. If the rs7517862-C/C genotype is detected, a high risk of developing diabetic foot syndrome is predicted in residents of Central Russia with type 2 diabetes.
EFFECT: invention makes it possible to implement preventive measures for diabetic foot syndrome in patients with type 2 diabetes mellitus at risk.
1 cl, 1 tbl, 1 ex
Authors
Dates
2024-01-16—Published
2023-11-23—Filed